Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.
Open Access
- 1 October 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 74 (4), 1221-1228
- https://doi.org/10.1172/jci111531
Abstract
Studies were performed on a French-Canadian family afflicted with a bleeding disorder exhibiting an autosomal dominant inheritance pattern and a severe bleeding diathesis after trauma. Clinical laboratory coagulation tests were unimpressive; the only persistent abnormalities include mild thrombocytopenia and moderately reduced Factor V clotting activities. Some individuals had prolonged Stypven times when platelet-rich plasma was used, suggesting that their platelets could not support functional prothrombinase complex assembly. Detailed studies were performed by use of plasma and isolated, washed platelets from a sister and brother. Bioassay data indicate that both individuals had Factor V activities of approximately 40 and 36% of normal, respectively. A comparison of the Factor V radioimmunoassay and bioassay data on the brother's plasma indicated that the circulating amount of Factor V functional activity was low relative to Factor V antigen concentration (approximately 65-75%). In both individuals, the platelet Factor V functional activities were extremely low (2-4%) relative to antigen levels present as determined by radioimmunoassay. These discrepancies between Factor V activities and antigen concentration do not appear to be due to an unstable Factor V molecule or to the presence of a Factor V or Factor Va inhibitor or inactivator. Kinetics of prothrombin activation by use of purified clotting factors indicated that thrombin-activated platelets from both individuals supported prothrombinase complex assembly identical to controls in the presence of added purified Factor Va. Consequently, their bleeding diathesis appears to reflect their platelet, rather than their plasma, Factor V activity. These results suggest that platelet Factor V is an essential component in maintaining stable and prolonged hemostasis after trauma.This publication has 34 references indexed in Scilit:
- Properties of the factor Xa binding site on human platelets.Journal of Biological Chemistry, 1978
- Patients with Congenital Factor V Deficiency have Decreased Factor Xa Binding Sites on their PlateletsJournal of Clinical Investigation, 1978
- Prothrombin structure, activation, and biosynthesisPhysiological Reviews, 1977
- [13] ProthrombinMethods in Enzymology, 1976
- Human prothrombin activation.1975
- Preparation and partial characterization of two forms of bovine thrombinBiochemical and Biophysical Research Communications, 1975
- Basic Mechanisms in Blood CoagulationAnnual Review of Biochemistry, 1975
- Inherited Variants of Factor-VIII-Related Protein in von Willebrand's DiseaseNew England Journal of Medicine, 1974
- Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation. RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENTJournal of Clinical Investigation, 1973
- Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII)Journal of Clinical Investigation, 1971